Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Autoimmune Disorders

Free Subscription 18.03.2019 1 Ann Neurol 1 Diabetes Res Clin Pract 4 J Autoimmun 2 J Clin Endocrinol Metab 2 J Neuroimmunol 2 J Neurol 4 J Pediatr Endocrinol Metab 4 J Rheumatol 1 Kidney Int 1 Nat Rev Neurol 1 Neurol Clin Pract 7 Neurology 1 PLoS Genet 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Neurol

1. CREE BAC, Hollenbach JA, Bove R, Kirkish G, et al
   Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis.
   Ann Neurol. 2019 Mar 9. doi: 10.1002/ana.25463.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes Res Clin Pract

2. URBANOVA J, Brunerova L, Broz J
   Heterogeneity of gestational diabetes - Do we take MODY into consideration as much as we should?
   Diabetes Res Clin Pract. 2019;148:268-269.
   PubMed     Text format    
   
   

   
   J Autoimmun

3. XIAO N, Wei J, Xu S, Du H, et al
   cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
   J Autoimmun. 2019 Mar 11. pii: S0896-8411(19)30035.
   PubMed     Text format     Abstract available
   
   
4. WENDEL S, Venhoff N, Frye BC, May AM, et al
   Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases.
   J Autoimmun. 2019 Mar 9. pii: S0896-8411(18)30742.
   PubMed     Text format     Abstract available
   
   
5. BING SJ, Shemesh I, Chong WP, Horai R, et al
   AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
   J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30020.
   PubMed     Text format     Abstract available
   
   
6. YAMAMOTO E, Jorgensen TN
   Immunological effects of vitamin D and their relations to autoimmunity.
   J Autoimmun. 2019 Mar 7. pii: S0896-8411(19)30033.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Endocrinol Metab

7. VENNERI MA, Hasenmajer V, Fiore D, Sbardella E, et al
   Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study.
   J Clin Endocrinol Metab. 2018;103:2998-3009.
   PubMed     Text format     Abstract available
   
   
8. PARIANI N, Willis M, Muller I, Healy S, et al
   Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features.
   J Clin Endocrinol Metab. 2018 Jun 6. pii: 5033322. doi: 10.1210/jc.2018-00359.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

9. AMMITZBOLL C, Bornsen L, Petersen ER, Oturai AB, et al
   Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.
   J Neuroimmunol. 2019;330:90-95.
   PubMed     Text format     Abstract available
   
   
10. CIERNY D, Michalik J, Dubovan P, Skerenova M, et al
    The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks.
    J Neuroimmunol. 2019;330:123-129.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

11. AL-ANSARI A, Robertson NP
    Autoimmune encephalitis: frequency and prognosis.
    J Neurol. 2019 Mar 15. pii: 10.1007/s00415-019-09273.
    PubMed     Text format    
    
    
12. FRAU J, Coghe G, Lorefice L, Fenu G, et al
    Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.
    J Neurol. 2019 Mar 12. pii: 10.1007/s00415-019-09272.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Endocrinol Metab

13. BABU KLG, Subramaniam P, Kaje K
    Assessment of dental caries and gingival status among a group of type 1 diabetes mellitus and healthy children of South India - a comparative study.
    J Pediatr Endocrinol Metab. 2018;31:1305-1310.
    PubMed     Text format     Abstract available
    
    
14. PUTAREK K, Banfic L, Pasalic M, Krnic N, et al
    Arterial stiffness as a measure of cardiovascular risk in obese adolescents and adolescents with diabetes type 1.
    J Pediatr Endocrinol Metab. 2018;31:1315-1323.
    PubMed     Text format     Abstract available
    
    
15. BAYRAMOGLU E, Elmaogullari S, Sagsak E, Aycan Z, et al
    Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
    J Pediatr Endocrinol Metab. 2019.
    PubMed     Text format     Abstract available
    
    
16. DOS SANTOS TJ, Passone CGB, Ybarra M, Ito SS, et al
    Pitfalls in the diagnosis of insulin autoimmune syndrome (Hirata's disease) in a hypoglycemic child: a case report and review of the literature.
    J Pediatr Endocrinol Metab. 2019.
    PubMed     Text format     Abstract available
    
    

    
    J Rheumatol

17. TERRE A, Talbot A, Louvrier C, Picque JB, et al
    Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?
    J Rheumatol. 2019 Mar 15. pii: jrheum.181204. doi: 10.3899/jrheum.181204.
    PubMed     Text format     Abstract available
    
    
18. LI C, Yap DYH, Chan G, Wen YB, et al
    Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773.
    PubMed     Text format     Abstract available
    
    
19. WITCZAK BN, Hetlevik SO, Sanner H, Barth Z, et al
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180526. doi: 10.3899/jrheum.180526.
    PubMed     Text format     Abstract available
    
    
20. DUMONT A, Parienti JJ, Delmas C, Boutemy J, et al
    Factors Associated with Relapse and Dependence to Glucocorticoids in Giant-Cell Arteritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181127. doi: 10.3899/jrheum.181127.
    PubMed     Text format     Abstract available
    
    

    
    Kidney Int

21. KRONBICHLER A, Jayne DRW
    ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?
    Kidney Int. 2018;94:1045-1047.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Neurol

22. FYFE I
    New rat model recapitulates disabling grey matter damage in multiple sclerosis.
    Nat Rev Neurol. 2019 Mar 14. pii: 10.1038/s41582-019-0168.
    PubMed     Text format    
    
    

    
    Neurol Clin Pract

23. SANTOS E, Silva AM, Stroebel P, Marinho A, et al
    Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.
    Neurol Clin Pract. 2019;9:48-52.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

24. LEWIS A, Galetta S
    Editors' note: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2019;92:542.
    PubMed     Text format    
    
    
25. KEARNEY H
    Reader response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2019;92:542-543.
    PubMed     Text format    
    
    
26. BAR-OR A, Grove RA, Tolson JM, Derosier FJ, et al
    Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
    Neurology. 2019;92:543.
    PubMed     Text format    
    
    
27. YEH EA, Eshaghi A
    Evolution of regional brain atrophy in children with multiple sclerosis: Gray matters.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007254.
    PubMed     Text format    
    
    
28. FOX RJ, Cosenza C, Cripps L, Ford P, et al
    A survey of risk tolerance to multiple sclerosis therapies.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007245.
    PubMed     Text format     Abstract available
    
    
29. DE MEO E, Meani A, Moiola L, Ghezzi A, et al
    Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5-year MRI study.
    Neurology. 2019 Mar 13. pii: WNL.0000000000007267.
    PubMed     Text format     Abstract available
    
    
30. KALINCIK T
    Effectiveness of oral multiple sclerosis therapies in clinical context.
    Neurology. 2019 Mar 15. pii: WNL.0000000000007300.
    PubMed     Text format    
    
    

    
    PLoS Genet

31. CHI C, Shao X, Rhead B, Gonzales E, et al
    Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.
    PLoS Genet. 2019;15:e1007808.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

32. GRACIA F, Larreategui M, Rodriguez G, Benzadon A, et al
    Costs of multiple sclerosis in Panama from societal, patient perspectives and health-related quality of life.
    PLoS One. 2018;13:e0204681.
    PubMed     Text format     Abstract available
    
    
33. TAKAHASHI A, Moriya K, Ohira H, Arinaga-Hino T, et al
    Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
    PLoS One. 2018;13:e0204772.
    PubMed     Text format     Abstract available
    
    
34. KALKOWSKI L, Malysz-Cymborska I, Golubczyk D, Janowski M, et al
    MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine.
    PLoS One. 2018;13:e0204650.
    PubMed     Text format     Abstract available
    
    
35. UGARTE-BERZAL E, Berghmans N, Boon L, Martens E, et al
    Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0197944.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

36. XU Q, Jin X, Zheng M, Rohila D, et al
    Phosphatase PP2A is essential for TH17 differentiation.
    Proc Natl Acad Sci U S A. 2019;116:982-987.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: